Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Other Non-Current Liabilities: 2019-2021

Historic Other Non-Current Liabilities for Pharming Group N.V (PHAR) over the last 3 years, with Dec 2021 value amounting to -$25,000.

  • Pharming Group N.V's Other Non-Current Liabilities fell 20.64% to -$25,000 in Q4 2021 from the same period last year, while for Dec 2021 it was -$25,000, marking a year-over-year decrease of 20.64%. This contributed to the annual value of -$25,000 for FY2021, which is 20.64% down from last year.
  • Latest data reveals that Pharming Group N.V reported Other Non-Current Liabilities of -$25,000 as of FY2021, which was down 20.64% from -$20,722 recorded in FY2020.
  • Pharming Group N.V's 5-year Other Non-Current Liabilities high stood at -$20,722 for FY2020, and its period low was -$19.8 million during FY2019.
  • Its 3-year average for Other Non-Current Liabilities is -$6.6 million, with a median of -$25,000 in 2021.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 99.90% in 2020, then declined by 20.64% in 2021.
  • Pharming Group N.V's Other Non-Current Liabilities (Yearly) stood at -$19.8 million in 2019, then skyrocketed by 99.90% to -$20,722 in 2020, then decreased by 20.64% to -$25,000 in 2021.